rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

SCYNEXIS, Inc.

SCYX · Nasdaq

Health CareBiotechnologyNot moving yet

SCYX stood above a rising 150-day average in 10 of the last 52 weekly readings, and has been out of that trend for the last 24 weeks. It is 33.3% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 24
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
38 (-3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 10 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months1
Sale orders, 12 months0
Buyers · sellers1 · 0
WhoDidSharesTraded
Gonzalez David AnguloChief Executive Officerbought108,6951 Apr 2026filed 2 Apr 2026
Gonzalez David AnguloChief Executive Officerbought108,6951 Apr 2026filed 2 Apr 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders38-3 on the quarter
New · exited11 · 14
Reported value$20.5M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
GREAT POINT PARTNERS LLCreduced · filed 14 Aug 2026944,292$3.8M-6,610,055−87.5%
Squadron Capital Management LLCreduced · filed 14 Aug 2026756,884$3.1M-6,851,811−90.1%
ADAGE CAPITAL PARTNERS GP, L.L.C.new · filed 14 Aug 2026543,478$2.2M+543,478
Propel Bio Management, LLCnew · filed 13 Aug 2026543,478$2.2M+543,478
Woodline Partners LPnew · filed 14 Aug 2026387,520$1.6M+387,520
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026296,747$1.2M-1,267,651−81.0%
Avidity Partners Management LPreduced · filed 14 Aug 2026260,206$1.1M-1,821,454−87.5%
KINGDON CAPITAL MANAGEMENT, L.L.C.reduced · filed 14 Aug 2026247,811$1.0M-1,734,680−87.5%
MILLENNIUM MANAGEMENT LLCreduced · filed 14 Aug 2026180,788$736K-441,373−70.9%
HEIGHTS CAPITAL MANAGEMENT, INCreduced · filed 14 Aug 2026150,551$613K-1,936,409−92.8%
31 Mar 2023 – 30 Jun 2026
344352Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Steven Keith Burke Company insiderDirector · last 18 Sep 20260 · 0
Sanjay Subramanian Company insiderChief Financial Officer · last 9 Sep 20260 · 0
Ann Hanham Company insiderDirector · last 26 Jun 20262 · 0
Armando Anido Company insiderDirector · last 26 Jun 20261 · 0
Brian Philippe Tinmouth Company insiderDirector · last 26 Jun 20261 · 0
David C. Hastings Company insiderDirector · last 26 Jun 20262 · 0
Guy Macdonald Company insiderDirector · last 26 Jun 20262 · 0
Gonzalez David Angulo Company insiderChief Executive Officer · last 1 Apr 202614 · 0
ivor Macleod Company insiderChief Financial Officer · last 29 Jan 20260 · 0
Scott Sukenick Company insiderChief Legal Officer · last 29 Jan 20263 · 0
Steven C. Gilman Company insiderDirector · last 26 Jun 20251 · 0
Marco Taglietti Company insiderChief Executive Officer · last 26 Apr 202231 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

From its SEC filings

Operating profit marginFY 2025 · to 31 Dec 2025-78.0%
Return on capital employedFY 2025 · to 31 Dec 2025-30.2%
Research spendFY 2025 · to 31 Dec 2025108%
Share count trendFY 2025 · to 1 Mar 20262.6%
Cash and equivalentsFY 2025 · to 31 Dec 2025$21.3M

Analyst forecasts

No analyst forecasts yet.